Post-treatment fulminant hepatic failure in an infant with Visceral leishmaniasis: Immune injury or stibogluconate toxicity?
- PMID: 19936650
- DOI: 10.1007/s12098-009-0265-0
Post-treatment fulminant hepatic failure in an infant with Visceral leishmaniasis: Immune injury or stibogluconate toxicity?
Similar articles
-
Sodium stibogluconate.Clin Infect Dis. 2006 Nov 15;43(10):1371-2. doi: 10.1086/508659. Clin Infect Dis. 2006. PMID: 17051510 No abstract available.
-
Acute pancreatitis associated with sodium stibogluconate treatment in a patient with human immunodeficiency virus.Arch Intern Med. 1996 May 13;156(9):1029, 1032. doi: 10.1001/archinte.156.9.1029. Arch Intern Med. 1996. PMID: 8624172 No abstract available.
-
Antimony-induced cerebellar ataxia.Saudi Med J. 2006 Jan;27(1):90-2. Saudi Med J. 2006. PMID: 16432602
-
[Treatment of visceral leishmaniasis in children].Med Trop (Mars). 2007 Feb;67(1):73-8. Med Trop (Mars). 2007. PMID: 17506279 Review. French.
-
Successful use of miltefosine and sodium stibogluconate, in combination, for the treatment of an HIV-positive patient with visceral leishmaniasis: a case report and brief review of the literature.Ann Trop Med Parasitol. 2009 Jul;103(5):455-9. doi: 10.1179/136485909X451753. Ann Trop Med Parasitol. 2009. PMID: 19583915 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources